Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02LHQ
|
||||
| Former ID |
DNC013261
|
||||
| Drug Name |
3-(2,4-dihydroxyphenyl)propionic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C9H10O4
|
||||
| Canonical SMILES |
C1=CC(=C(C=C1O)O)CCC(=O)O
|
||||
| InChI |
1S/C9H10O4/c10-7-3-1-6(8(11)5-7)2-4-9(12)13/h1,3,5,10-11H,2,4H2,(H,12,13)
|
||||
| InChIKey |
HMCMTJPPXSGYJY-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Tyrosine oxidase | Target Info | Inhibitor | [1] | |
| BioCyc Pathway | (S)-reticuline biosynthesis | ||||
| Eumelanin biosynthesis | |||||
| L-dopachrome biosynthesis | |||||
| KEGG Pathway | Tyrosine metabolism | ||||
| Riboflavin metabolism | |||||
| Metabolic pathways | |||||
| Melanogenesis | |||||
| PathWhiz Pathway | Riboflavin Metabolism | ||||
| Tyrosine Metabolism | |||||
| WikiPathways | Dopamine metabolism | ||||
| References | |||||
| REF 1 | J Med Chem. 2007 May 31;50(11):2676-81. Epub 2007 Apr 21.Enhanced substituted resorcinol hydrophobicity augments tyrosinase inhibition potency. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.